Amgen Manufacturing Limited (manufacturing unpackaged products, primary packaging)

The drug is indicated for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also used to treat bone loss in men receiving hormone suppression therapy for prostate cancer, and in patients with bone loss due to long-term glucocorticoid therapy.

Dosage form: solution for injection

ATC: M05BX04